Breakthrough light activated drug device investigated for treatment of HPV and cervical pre-cancer. http://www.sagentia.com/photocure-hpv-device

1. The approach
This is the first therapeutic treatment that uses advanced LED
technology in a self-powered, disposable device which can be
deployed inside a body cavity. The device contains a LED light
source that in combination with a medicinal product initiates a
photochemical reaction in exposed tissue.
The end result
“This is the first ever non-surgical treatment for HPV and
precancerous lesions of the cervix to be successfully
developed. If this sophisticated and breakthrough device is
accepted, it will make way for a new era in cervical cancer
treatment that will not only minimise patient risk and suffering
but could also help reduce the burden of HPV on healthcare
systems.”
Dr. Peter Hillemanns, Professor and Chairman
at the Department of Obstetrics and
Gynecology of Medical University
Hannover and
Principal investigator
for the trial
Photocure
Breakthrough light activated drug
device investigated for treatment of
HPV and cervical pre-cancer